White label ELPA - ClinicalTrials.eu

Study on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Durvalumab
Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Not recruiting

3 1 1 1
Investigated Diseases:
- Pseudomonas infection
Investigated Drugs:
Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Short-bowel syndrome
Investigated Drugs:
- Apraglutide
+5
Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

Not recruiting

2 1 1
Investigated Diseases:
- Anaemia
- Myelodysplastic syndrome
Investigated Drugs:
- 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia (in remission)
Investigated Drugs:
- Decitabine
- Venetoclax
Study of Tepotinib and Osimertinib for Patients with Advanced or Metastatic Lung Cancer Resistant to Osimertinib Therapy

Not recruiting

2 1 1 1
Investigated Drugs:
- Tepotinib
- Osimertinib
Study of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)

Not recruiting

3 1 1
Investigated Diseases:
- Hypereosinophilic syndrome
Investigated Drugs:
- Benralizumab
+3
Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Waldenstrom’s macroglobulinaemia
Investigated Drugs:
Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+1
Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Ocrelizumab
+14

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies